| Company/Division name | Bayer Corporation |
| Parent company | Bayer AG |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2019 |
| Year reshoring implemented or to be implemented: | 2021 |
| Capital investment ($): | 150 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Berkeley |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell culture technology |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customer responsiveness improvement, Eco-system synergies, Higher productivity, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D) |
